Jefferies Financial Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.38M Sell
22,500
-8,000
-26% -$870K 0.02% 510
2026
Q1
$2.82M Sell
30,500
-60,500
-66% -$6.07M 0.02% 498
2025
Q4
$9.29M Sell
91,000
-32,000
-26% -$2.86M 0.05% 337
2025
Q3
$7.69M Buy
123,000
+83,000
+208% +$4.52M 0.04% 270
2025
Q2
$2.08M Buy
+40,000
New +$1.79M 0.02% 517
2024
Q2
Sell
-81,100
Closed -$1.67M 1569
2024
Q1
$1.67M Buy
+81,100
New +$1.74M 0.02% 651

Other funds holding GH

Jefferies Financial Group's GH Position: Q2 2026 in Review

Jefferies Financial Group increased its Guardant Health (GH) stake by 89% in Q2 2026, buying an estimated $1.82M and bringing the position to 35,629 shares worth $5.35M. The position accounts for 0.04% of the portfolio, ranked #373.

Jefferies Financial Group first reported a position in GH in Q3 2024 and has held it in 6 quarters since. The position peaked at $6.53M in Q4 2025. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Jefferies Financial Group held 35,629 shares of Guardant Health worth $5.35M as of Q2 2026.
  • Jefferies Financial Group bought 16,750 Guardant Health shares in Q2 2026, an estimated $1.82M.
  • Guardant Health made up 0.04% of Jefferies Financial Group's portfolio in Q2 2026, its #373 holding.
  • Jefferies Financial Group first reported a position in Guardant Health in Q3 2024 and has held it in 6 quarters since.
  • Jefferies Financial Group's Guardant Health position peaked at $6.53M in Q4 2025.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.